New MRI method could speed up bladder cancer diagnosis
NCT ID NCT05779631
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares a new diagnostic approach—using an MRI plus a same-day biopsy—against the standard procedure (TURBT) for diagnosing muscle-invasive bladder cancer. Researchers will enroll 360 adults suspected of having this aggressive cancer. The goal is to see if the new method leads to faster treatment and better outcomes, such as longer survival without the cancer spreading.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
mpMRI plus same-day cystoscopic bladder biopsy
What this could lead to
If successful, this could replace the standard two-step diagnosis with a faster, single-day procedure, potentially improving survival by starting treatment sooner.
What could go wrong
This is a diagnostic study, not a treatment trial. The MRI approach may not prove more effective than current methods, and some patients may still need additional procedures.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Amsterdam UMC, location AMC
RECRUITINGAmsterdam, Netherlands
-
Amsterdam UMC, location VUmc
RECRUITINGAmsterdam, Netherlands
-
Antoni van Leeuwenhoek - Netherlands Cancer Institute
RECRUITINGAmsterdam, Netherlands
-
Bernhoven ziekenhuis
RECRUITINGUden, Netherlands
-
Canisius Wilhelmina Ziekenhuis
RECRUITINGNijmegen, Netherlands
-
Erasmus Medical Center
NOT_YET_RECRUITINGRotterdam, Netherlands
-
Jeroen Bosch ziekenhuis
RECRUITING's-Hertogenbosch, Netherlands
-
Maasziekenhuis Pantein
RECRUITINGBoxmeer, Netherlands
-
Meander MC
NOT_YET_RECRUITINGAmersfoort, Netherlands
-
Medisch Spectrum Twente
NOT_YET_RECRUITINGEnschede, Netherlands
-
OLVG
RECRUITINGAmsterdam, Netherlands
-
Radboud university medical center
RECRUITINGNijmegen, Netherlands
-
Rijnstate ziekenhuis
RECRUITINGArnhem, Netherlands
-
St. Antonius ziekenhuis
RECRUITINGNieuwegein, Netherlands
-
Treant
NOT_YET_RECRUITINGEmmen, Netherlands
-
University Medical Center Utrecht
RECRUITINGUtrecht, Netherlands
-
VieCuri medisch centrum
RECRUITINGVenlo, Netherlands
-
Ziekenhuis Gelderse Vallei
RECRUITINGEde, Netherlands
-
Ziekenhuisgroep Twente
RECRUITINGAlmelo, Netherlands